JP2014500263A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500263A5
JP2014500263A5 JP2013540910A JP2013540910A JP2014500263A5 JP 2014500263 A5 JP2014500263 A5 JP 2014500263A5 JP 2013540910 A JP2013540910 A JP 2013540910A JP 2013540910 A JP2013540910 A JP 2013540910A JP 2014500263 A5 JP2014500263 A5 JP 2014500263A5
Authority
JP
Japan
Prior art keywords
composition
biotec
bcc
deposited
culture collection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013540910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014500263A (ja
JP5913353B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/MY2010/000307 external-priority patent/WO2012074351A1/en
Publication of JP2014500263A publication Critical patent/JP2014500263A/ja
Publication of JP2014500263A5 publication Critical patent/JP2014500263A5/ja
Application granted granted Critical
Publication of JP5913353B2 publication Critical patent/JP5913353B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013540910A 2010-11-29 2010-11-29 腫瘍細胞毒性剤およびその方法 Expired - Fee Related JP5913353B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MY2010/000307 WO2012074351A1 (en) 2010-11-29 2010-11-29 Tumour cytotoxic agent and methods thereof

Publications (3)

Publication Number Publication Date
JP2014500263A JP2014500263A (ja) 2014-01-09
JP2014500263A5 true JP2014500263A5 (enExample) 2014-02-20
JP5913353B2 JP5913353B2 (ja) 2016-04-27

Family

ID=46172112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013540910A Expired - Fee Related JP5913353B2 (ja) 2010-11-29 2010-11-29 腫瘍細胞毒性剤およびその方法

Country Status (7)

Country Link
US (2) US9480721B2 (enExample)
EP (1) EP2646042A4 (enExample)
JP (1) JP5913353B2 (enExample)
KR (1) KR101747815B1 (enExample)
BR (1) BR112012021624A2 (enExample)
SG (1) SG183544A1 (enExample)
WO (1) WO2012074351A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102735818B1 (ko) 2015-01-23 2024-11-28 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 암 예방에서 단쇄 지방산의 용도
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
CN115551990B (zh) 2020-02-26 2024-09-20 Gi生物群系公司 瑞士乳杆菌菌株及含有其的用于预防或治疗炎性疾病的组合物
JP2023544310A (ja) * 2020-09-30 2023-10-23 チェンドゥ クァチャンアオプー メディカル テクノロジー カンパニー リミテッド プロバイオティクス成分の使用及びプロバイオティクス成分を含む医薬組成物
JP7594826B2 (ja) * 2021-03-22 2024-12-05 ジーアイ バイオーム ラクトバチルス・プランタルムgb104株及びそれを含むがんの予防又は処置のための組成物
EP4477227A4 (en) * 2022-02-10 2025-06-11 Gi Biome Inc. Composition for the prevention or treatment of cancer with combined therapy with Lactobacillus plantarum strain and anticancer agent
CN116144530B (zh) * 2022-11-17 2023-07-21 朗恒科技集团有限公司 一株植物乳杆菌ay01及其应用
KR20240123764A (ko) * 2023-02-06 2024-08-14 주식회사 지아이바이옴 락토바실러스 플란타룸 균주 및 면역세포의 병용 요법을 이용한 암 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009093447A1 (ja) * 2008-01-22 2009-07-30 National University Corporation Asahikawa Medical College 消化器癌に対する抗腫瘍剤
WO2010064373A1 (ja) * 2008-12-04 2010-06-10 国立大学法人広島大学 Il-8阻害剤およびその製造方法
AU2009344224B2 (en) * 2009-04-09 2015-08-20 Universiti Putra Malaysia (Upm) Monogastric animal feed
MY158907A (en) * 2009-08-10 2016-11-30 Univ Putra Malaysia Upm Metabolites in animal feed

Similar Documents

Publication Publication Date Title
JP2014500263A5 (enExample)
JP2014158488A5 (enExample)
NZ608432A (en) Gel composition
RU2010142489A (ru) Штамм lactobacillus rhamnosus
JP2013517784A5 (enExample)
JP2016537410A5 (enExample)
FI2787843T4 (fi) Menetelmä pakastekuivatun mikro-organismikoostumuksen valmistamiseksi
JP2008538288A5 (enExample)
CN102618452B (zh) 唾液乳杆菌及其代谢物的制备方法和组合物以及应用
RU2012134407A (ru) Способ приготовления биомассы, содержащей плантарицин, и ее применение в медицинских целях
FR2888468B1 (fr) Produits alimentaires fermentes contenant des souches probiotiques, et leur procede de preparation
RU2014129803A (ru) Новый штамм lactobacillus mucosae
CN110023486A (zh) 一种嗜酸乳杆菌及其培养方法和应用
FI20075539A0 (fi) Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
RU2016143922A (ru) Терапевтическое средство для применения в лечении опухолей, синдрома приобретенного иммунодефицита и лейкозов путем двойной иммунной биостимуляции
Zhang et al. Apoptosis of human tongue squamous cell carcinoma cell (CAL-27) induced by Lactobacillus sp. A-2 metabolites
CN110023484A (zh) 一种假小链状双歧杆菌及其培养方法和应用
JP2014526266A5 (enExample)
FR2888469B1 (fr) Produits alimentaires fermentes contenant des souches probiotiques, et leur procede de preparation
JP2015533484A5 (enExample)
JP2008266291A5 (enExample)
WO2012042223A3 (en) Foodstuff fermented with a lactic acid producing bacteria
JP2012055288A (ja) 安定化された生菌製剤およびその製造方法。
WO2011133681A3 (en) Low/high dose probiotic supplements and methods of their use
WO2012138477A3 (en) Probiotic bacterial strains and method of use to decrease mortality due to bacterial disease